Stock Performance and Market Context
On 5 May 2026, Integrated Proteins Ltd’s stock price opened and traded steadily at Rs.108.20, setting a new 52-week and all-time high. The stock recorded a day gain of 1.98%, outperforming the Sensex which declined by 0.67% on the same day. Despite underperforming its sector’s solvent extraction segment, which gained 4.24%, the stock has demonstrated resilience with a two-day consecutive gain, delivering a 3.89% return over this short period.
Over longer time frames, the stock’s performance has been exceptional. It has surged 42.97% in the past month, vastly outpacing the Sensex’s 4.68% gain. The three-month return stands at an impressive 285.05%, while the one-year performance is up 138.64%, compared to the Sensex’s negative 5.01%. Year-to-date, the stock has soared 214.53%, contrasting with the Sensex’s decline of 9.94%. Over three years, Integrated Proteins Ltd has delivered a staggering 881.85% return, far exceeding the Sensex’s 25.71% growth. The ten-year performance is even more remarkable, with a 4956.07% increase against the Sensex’s 203.81%.
Technical Analysis and Trend Indicators
The stock’s technical profile supports the bullish momentum. Since 27 March 2026, when the trend shifted from sideways to bullish at Rs.71.33, Integrated Proteins Ltd has maintained an upward trajectory. It currently trades above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong market support.
Technical indicators present a predominantly positive outlook. The MACD and Bollinger Bands show bullish signals on both weekly and monthly charts. Moving averages reinforce this trend, while the KST indicator is mildly bearish on the monthly scale but bullish weekly. The RSI indicator is bearish weekly but shows no signal monthly. Immediate support is identified at the 52-week low of Rs.20.71, with resistance levels previously noted at Rs.91.10 (20-day moving average) and Rs.48.69 (100-day moving average) now surpassed. The stock’s current price at Rs.108.20 represents a new resistance level.
Delivery volumes have also increased significantly, with a 159.4% rise in one-day delivery compared to the five-day average, and a 24.37% increase over the trailing one-month period. This suggests heightened trading activity accompanying the price rise.
Valuation Metrics and Financial Overview
At the all-time high price of Rs.108.20, Integrated Proteins Ltd’s valuation multiples reflect a premium positioning. The price-to-earnings (P/E) ratio stands at 602 times trailing twelve months (TTM), indicating high market expectations relative to earnings. The price-to-book value (P/BV) ratio is 9.76 times, while enterprise value multiples such as EV/EBITDA and EV/EBIT both register at 198.55 times. The EV/Sales ratio is 7.73 times, and EV/Capital Employed is 9.76 times. The PEG ratio is not available.
Dividend metrics show no yield or payout, consistent with the company’s current financial policy. The absence of dividend payments aligns with the company’s reinvestment strategy and growth focus.
Quality Assessment and Financial Health
Integrated Proteins Ltd’s overall quality grade is below average, reflecting certain financial performance challenges despite strong sales growth. The company has achieved a five-year sales compound annual growth rate (CAGR) of 92.87%, demonstrating robust top-line expansion. However, EBIT growth over five years is more modest at 7.26%, and average EBIT to interest coverage is weak at -0.05 times.
Capital structure indicators show low leverage, with an average debt-to-EBITDA ratio of 0.46 and net debt to equity at zero, indicating a strong balance sheet with negligible debt. The average sales to capital employed ratio is 0.48 times, and the tax ratio stands at 21.43%. Return metrics reveal an average return on capital employed (ROCE) of -5.14% and return on equity (ROE) of 1.51%, both reflecting limited profitability. The company maintains zero pledged shares and low institutional holdings.
Financial Trend and Short-Term Outlook
The short-term financial trend as of December 2025 is flat, with quarterly earnings per share (EPS) at a low of Rs.-0.06. This indicates that while the stock price has surged, earnings performance remains subdued in the near term.
Summary of Market Capitalisation and Ratings
Integrated Proteins Ltd is classified as a micro-cap company. According to MarketsMOJO, the stock holds a Mojo Score of 44.0 and a current Mojo Grade of Sell, upgraded from a previous Strong Sell on 27 March 2026. This rating reflects a cautious stance despite the recent price appreciation and technical strength.
Conclusion
The attainment of an all-time high price of Rs.108.20 by Integrated Proteins Ltd on 5 May 2026 marks a significant milestone in the company’s market journey. Supported by strong multi-year returns, a bullish technical trend, and increased trading volumes, the stock’s performance stands out within the edible oil sector. While valuation multiples are elevated and quality metrics indicate areas for improvement, the company’s sustained sales growth and solid balance sheet underpin its current market valuation. This milestone encapsulates a period of notable market confidence and price momentum for Integrated Proteins Ltd.
